Last month, the US Food and Drug Administration (FDA) released its latest guidance, Communications from Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products: Questions and Answers. In this final guidance, the FDA describes recommendations for medical product manufacturers intending to disseminate
It